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Abstract
Background and Methodology: The aim of this study was to establish a gene expression blueprint of pancreatic beta cells
conserved from rodents to humans and to evaluate its applicability to assess shifts in the beta cell differentiated state.
Genome-wide mRNA expression profiles of isolated beta cells were compared to those of a large panel of other tissue and
cell types, and transcripts with beta cell-abundant and -selective expression were identified. Iteration of this analysis in
mouse, rat and human tissues generated a panel of conserved beta cell biomarkers. This panel was then used to compare
isolated versus laser capture microdissected beta cells, monitor adaptations of the beta cell phenotype to fasting, and
retrieve possible conserved transcriptional regulators.
Principal Findings: A panel of 332 conserved beta cell biomarker genes was found to discriminate both isolated and laser
capture microdissected beta cells from all other examined cell types. Of all conserved beta cell-markers, 15% were strongly
beta cell-selective and functionally associated to hormone processing, 15% were shared with neuronal cells and
associated to regulated synaptic vesicle transport and 30% with immune plus gut mucosal tissues reflecting active protein
synthesis. Fasting specifically down-regulated the latter cluster, but preserved the neuronal and strongly beta cell-
selective traits, indicating preserved differentiated state. Analysis of consensus binding site enrichment indicated major
roles of CREB/ATF and various nutrient- or redox-regulated transcription factors in maintenance of differentiated beta cell
phenotype.
Conclusions: Conserved beta cell marker genes contain major gene clusters defined by their beta cell selectivity or by their
additional abundance in either neural cells or in immune plus gut mucosal cells. This panel can be used as a template to
identify changes in the differentiated state of beta cells.
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Introduction
In this study we tried to establish a blueprint of the pancreatic
beta cell transcriptome conserved from rodents to humans.
Identification of novel beta cell-selective biomarkers can have
several (pre)clinical applications. Beta cell-selectively expressed
genes are likely important for beta cell survival and specialized
functions and could yield novel targets for drugs that regulate
glucose-sensing and insulin synthetic capacity of the beta cell.
They could also serve as candidate biomarkers for diagnostic
purposes, e.g. beta cell surface proteins for in vivo imaging of beta
cell mass, or to find targets for assays that detect beta cell
biomarkers that are specifically discharged from dying beta cells in
analogy to GAD65 [1]. A comprehensive view on beta cell-
selective biomarkers can also guide the preclinical development of
novel types of transplantable beta cell grafts: to solve the current
shortage in donor beta cells, studies are undertaken to generate
functional beta cells through differentiation of stem cells or
reprogramming of developmentally related cell types [2]. These
lab-generated beta cell preparations need to be extensively
evaluated in the preclinical phase, to ensure that their gene and
protein expression profiles and functional properties closely
resemble primary beta cells.
In the present study we used Affymetrix oligonucleotide arrays
to record the transcriptome of freshly isolated highly FACS-
purified rat beta cells (.90% insulin+), freshly isolated mouse islets
and cultured human beta cells obtained from 10 donor organs and
FACS-enriched to 655% insulin-positivity. In each species we
compared these to a large panel of mRNA profiles of other
primary tissues or cell types, and selected transcripts with relatively
abundant expression in the beta cell preparations. To filter out
inevitable experimental noise associated with each of these
comparisons, we focused only on marker genes that had a beta
cell-selective and – abundant expression in the three model
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24134species. Notwithstanding the fact that there are proven differences
in beta cell function and gene expression between rodents and
man, our focus on evolutionary conserved features serves as
additional argument for likely biological significance of identified
beta cell biomarkers.
In a second part of the study, the experimental usefulness of the
resulting conserved beta cell marker genes was evaluated. First, the
panel was used to compare beta cell preparations obtained by cell
isolation or in situ laser capture microdissection. Second, the panel
was used to examine how beta cell differentiated states is
dynamically regulated by fasting. Third, two different bioinfor-
matics algorithms were used to identify likely conserved transcrip-
tional regulators in the conserved beta cell biomarkers. Finally, we
confirmed beta cell-selective expression of the corresponding
proteins using quantitative LC-MS/MS analysis of unfractionated
beta cell proteomes and immunohistochemistry on pancreatic
sections. Protein phosphatase 1, regulatory (inhibitor) subunit 1A
(PPP1RIA) came out as a novel beta cell marker with high molar
protein abundance and beta cell-restricted expression in the
pancreas.
Results
Selection of conserved beta cell marker genes
In each of the three examined species, we selected a set of 2500
transcripts with higher expression in beta cells than in other tissues
(from 20% to 100-fold higher). Intersects were sought with
common annotated genes (Fig. 1) and only transcripts with
conserved relative beta cell abundance were further analyzed. This
restriction lowers comprehensiveness (sensitivity), but increases
robustness (specificity) of the resulting 395 candidate beta cell
marker transcripts, which represent 16% (mouse) to 31% (human)
of initial input genes. We then removed transcripts that can be
attributed to the pancreatic non-beta cell types that contaminate
beta cell preparations. We used mRNA profiles of FACS-purified
rat islet endocrine non-beta cells to remove 46 transcripts that are
at least 1.5-fold higher in alpha than in beta cells (p,0.05, n=3,
e.g. hormone-coding genes GLUC, PPY and SST). The human data
sets enabled removal of transcripts typical for exocrine duct (n=5)
or acinar (n=12) cells. As shown in Fig. S1, the contamination by
exocrine-associated genes is much lower in FACS-purified human
Figure 1. Selection algorithm of conserved beta cell marker genes. Beta cell preparations were compared to the indicated tissues in mouse,
rat and human and genes with conserved beta cell-abundant expression selected (Venn diagram intersect). The rat data set was used to discard 46
islet endocrine non-beta cell (mainly alpha cell) markers; the human data set enabled curation of 17 pancreatic exocrine (acinar and duct) markers.
Final set of conserved beta cell marker genes consists of 332 genes, represented by 419 (rat), 499 (mouse) or 503 (human) oligonucleotide probe sets.
doi:10.1371/journal.pone.0024134.g001
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of 332 genes with conserved beta cell-abundant expression (Table
S1, further referred to as beta cell marker genes) is represented by
419, 499 or 503 probe sets on the rat, mouse and human arrays
respectively.
Distribution of conserved beta cell marker genes over
three clusters with different tissue selectivity
The 332 beta cell marker genes were visualized for their natural
tissue tropism in the context of the Human Gene Atlas [3], a
public repository of mRNA expression profiles of human organs or
cell types. Beta cell-selectivity was independently confirmed for
most markers (Figure 2). The hierarchical cluster graph highlights
that most beta cell marker genes are also actively transcribed in
other cell or tissue types and few genes can be called beta cell-
specific. Combined however, our beta cell marker gene list clearly
discriminates beta cells from all other examined cell types: this is
graphically illustrated by the cluster tree in Figure 2 and its
associated principle component analysis (Fig. S2). In terms of their
overall tissue-selectivity, at least 60% of beta cell marker genes fall
into three main clusters; i.e. a neuroendocrine cluster (cluster A), a
beta cell cluster (cluster B) and a immune/gut enriched cluster
(cluster C) (Fig. 2).
Beta cell marker genes with high degree of beta cell-
selectivity
At least 15% of conserved beta marker genes (n=48) show near
absolute beta cell-selectivity (beta cell selective cluster B in Fig. 2,
exemplary genes shown in Fig. 3 and Fig. S4). This cluster
contains established beta cell markers such as hormones (INS2
IAPP) and hormone processing enzymes (PCSK1, CPE), transcrip-
tion factors (NKX2-2, INSM1), metabolic enzymes (HADH, G6PC2,
PFKFB2) and secretogranin proteins. It also reveals novel beta cell
markers such as putative tumor suppressor ST18, phosphatase
regulator PPP1R1A, ketone body-metabolizing enzyme AACS and
several RAB/RAS GTPase-associated proteins (RRAGD, RAB2A,
GARNL4)., mRNA expression of these markers is 10 to 15-fold
higher in beta cells than in other tissues. The cluster is statistically
enriched (p,0.001) in ontologies of hormone processing, protein folding
and secretory granules (Fig. S4).
Beta cell marker genes sharing selectivity with neuronal
cells
At least 15% of beta cell marker genes (n=47) are also
abundant in various brain regions (cluster A in Fig. 2, exemplary
genes shown in upper panel Fig. 3). Some have been previously
reported as beta cell markers (e.g. PTPRN2 alias IA-2b, DDIT3
and GLP1R); others were so far considered as brain-selective. This
cluster is enriched (p,0.001) in ontologies such as synaptic vesicle,
neurotransmitter transport and nervous system development. Examples of
genes involved in neuronal development or migration are
NEUROD, ROBO1, DCX and PAFAH1B1. Genes belonging to
this beta-cell cluster were found to be particularly transcribed in
the dopaminergic neurons of the globus pallidus (GP) and the
glutaminergic/GABAergic neurons of the subthalamic nucleus
(STN) (Fig. S3). An exemplary marker is dopa decarboxylase
(DCC), rate-limiting enzyme for biogenic amine synthesis, of which
the mRNA is 20-fold more abundant in beta cells than in whole
brain (Table 1).
Beta cell marker genes sharing selectivity with immune
and gut mucosa cells
Roughly 30% (n=99) of beta cell marker genes appear also
actively transcribed in immune cells, and to a lesser extent in
Figure 2. Shared gene clusters between beta cells, neuronal cells and immune cells. The 503 human probe sets corresponding to the 332
conserved beta cell marker genes are visualized by hierarchical clustering in the Human Genome Atlas data set [3]. At least 15% of beta cell marker
genes show near absolute beta cell selectivity (beta cell selective cluster B). Beta cells also share an equally extensive cluster (15%) with various brain
regions (neuroendocrine cluster A), and an even larger cluster (30%) with immune and gut mucosal cells (gut/immunological cluster C). Statistical
enrichment analysis indicates that these clusters accentuate different functions proper to the specialized beta cell phenotype. Blue to red correspond
low to high relative expression, as shown in legend (bottom). Relevant genes of clusters A, B and C are shown in Fig. 3.
doi:10.1371/journal.pone.0024134.g002
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Functionally these genes are enriched (p,0.001) in pathways
such as response to stress, small GTPase, protein folding and
endoplasmic reticulum, reflecting a role of many of these marker
genes in the synthesis and proper folding of secretory proteins in
the endoplasmic reticulum and Golgi. Compared to the other
two clusters, it shows a more moderate beta cell-selectivity with
only a 2 to 3-fold higher expression in beta cells than in other
tissues.
Quantitative real-time PCR confirmation of novel beta
cell markers
Beta cell selectivity of 27 marker genes – positive controls as well
as novel candidate markers from the three clusters – was verified
by qPCR in the rat model (Table 1). Use of geometric
normalization of marker mRNAs to 4 validated reference genes
[4] allows reliable quantification of mRNA abundances both
within and between different cell types. The selected beta cell
marker genes show large variations in their mRNA levels, with the
Figure 3. Examples of beta cell marker genes belonging to neuroendocrine cluster A, beta cell selective cluster B and beta-immune
cluster C. Average fold change (AvFC) indicates the relative abundance of a given mRNA in the beta cell as compared to the other tested tissues in
that species, while lower rank value reflects higher beta cell selectivity (see methods). From each tissue-tropic cluster (A, B, C from Fig. 2), beta cell
marker genes with, calculated for the 3 species, an averaged avFC score $4, are shown. Relative beta cell abundance (and selectivity) decreases from
cluster B over cluster A to cluster C, and consequently this is reflected in number of retained exemplary genes.
doi:10.1371/journal.pone.0024134.g003
Beta Cell Genes Conserved from Rodents to Humans
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24134most abundant mRNAs INS2 and IAPP respectively 10
5 and
5610
3 more abundant than the least abundant one, that of
transcription factor NKX2.2. Of note, none of the genes with the
exception of IAPP shows a truly beta cell-selective expression, since
low hybridization signals were detected in other tissues, notably
brain and gut. The strongest novel markers are ST18 – with
undetectable expression in all other cell types except brain - and
DCX, PPP1R1A and FOSB – which are detected in other tissues but
at much lower levels than in beta cells. Other markers show
abundant expression in islet endocrine cells with weak or no
selectivity towards either beta or alpha cell lineage, such as GCK,
PTPRN (IA2) and SCG5.
Figure 4. Conserved beta cell marker genes in isolated versus laser capture microdissected human beta cells. Panel A shows mRNA
expression signal on HG133A chip of 13 established pancreatic exocrine (acinar) genes, in freshly isolated human islets (islets, red bars, n=3), laser
capture microdissected beta cells (LCM, green bars, n=3) and 2–3 w cultured beta cells that were subsequently FACS-enriched (beta cells, blue bars,
n=3). * p,0.05 versus LCM. Panel B shows relative mRNA levels established beta cell-specific genes in cultured beta (blue), fresh islets (red) and LCM-
beta cells (green). Table shows fold change (LCB, lower confidence bound) and P values of versus LCM-beta.
doi:10.1371/journal.pone.0024134.g004
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PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24134Conserved beta cell markers obtained by analysis of
isolated beta cells also mark beta cells obtained by laser
capture microdissection
The panel of conserved beta cell markers was obtained by study
of isolated beta cell preparations. Cell isolation entails hypoxia,
mechanical stress, disruption of intercellular and cell-to-matrix
interactions and possibly contamination by exocrine pancreatic
cells. Since associated biases on gene expression are reportedly less
pronounced in beta cells obtained by laser capture microdissection
(LCM) [5], we compared mRNA profiles of cultured human beta
cells to published [5] profiles of freshly isolated islets and laser
capture microdissected (LCM)-beta cells. First we quantified
exocrine contamination. LCM-beta cells indeed showed 7-fold
lower mRNA expression of 13 acinar markers (p,0.05 for 9/13,
n=3) than freshly isolated islets but they expressed on the average
13-fold higher levels (p,0.05 for 3/13, range 22.8 to 73-fold)
than cultured beta cells (Fig. 4a).
Next we looked at signs of isolation-associated cell stress and
found no statistical enrichment in cultured beta cells of clusters
involved in HIF alpha signaling, TNF signaling or MAPK/ERK
signaling as reported for freshly isolated islets [5]. Cultured beta
cells did show however a significant (p,0.001) activation of genes
involved in unfolded protein binding, but this was accompanied by
significant (p,0.001) up-regulation of clusters with role in mRNA
splicing in the spliceosome, ribosomal subunits, translation initiation, protein
transport, ER to Golgi transport and vesicle-mediated secretion (Table S2),
reflecting concerted activation of the protein synthetic machinery
rather than unfolded protein response due to cell stress. This
associated with higher expression of genes coding for mitochon-
drial metabolic enzymes (Table S2).
Third, we compared isolated and LCM-beta cells for mRNA
level of classical beta cell marker genes and observed that most
established beta cell markers were more abundantly expressed in
cultured beta cells, with mRNAs of NEUROD1, NKX6.1, PCSK1,
HADH, G6PC2 and GLP1R 1.5 to 4-fold up (p,0.05, Fig. 4B). For
ATF3 differences were more dramatic, with 640-fold (p,0.03)
higher levels both in isolated islets and beta cells.
Finally, when compared to other human tissues, our panel of
conserved beta cell marker genes proved also abundantly
expressed in LCM beta cells (not shown), and consequently this
gene panel could equally well discern LCM and cultured beta cells
from all other tissue types, as shown in PCA graph in Fig. S2.
Use of conserved beta cell marker genes to identify
transcription factors important for maintenance of beta
cell differentiated state
Next we used the conserved biomarkers to identify correspond-
ing conserved transcriptional regulators. Two complementary
algorithms were used for identification of statistically overrepre-
sented transcription factor binding sites. First, the DiRE algorithm
[6] was used to scan for cis-regulatory motifs in conserved
promoter regions. This analysis was run on the full panel of beta
cell marker genes as well as on the three main clusters in terms of
tissue-tropism (Table S3). In a fully complementary strategy,
candidate promoter regions were searched for conserved enrich-
ment using a matrix-scan approach [7] (Table S4, Fig. 5). Motifs
Figure 5. In rat beta cells fasting down-regulates cluster C genes with role in ER function and protein processing. Heat map in Fig. 5A
shows the complete set of species-conserved beta cell markers, visualized in FACS-purified beta cells freshly isolated from control (FED) and 24-h
fasted (FAST) rats; one third is reproducibly $1.25-times down-regulated (blue window) most of which statistically significantly (21% of all beta
markers, p,0.05, n=3). Table in panel B shows the 42 beta markers that are at least 1.5-fold down-regulated (p,0.05) by fasting: 50% of the fasting-
suppressed beta cell marker genes belong to cluster C, also functionally enriched in pathways of protein folding and processing through ER/Golgi.
doi:10.1371/journal.pone.0024134.g005
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include members of the Creb/Atf (Creb, Atf6, Atf3), Pax (Pax4 or
Pax6) and Fox families, established beta cell transcription factors
Nkx2-2 and Pdx1 and several transcriptional regulators with likely
role in nutrient-redox regulated gene expression: upstream factors
(Usf), Arnt/HIF, yingyang 1 (YY1), Xbp1, Oct1, Nfat and Stra13.
Other overrepresented binding sites are those for transcription
factors mostly studied in relation to blood (Tal1, Meis, Hoxa9,
Gfi1b) or muscle (Myogenin, Tbx5, Rfx1, Mrf2) homeostasis. Of
these, Atf3, Pdx1 and Nkx2.2 are also beta cell-abundant at the
mRNA level. This is also the case for Foxa2, Nkx6.1, MyoD1, c-
Jun and FosB, which are only identified by the DiRE algorithm.
Use of conserved beta cell marker genes to evaluate
effect of fasting on beta cell differentiated state and
functional phenotype
Short periods of fasting are thought to mediate the beta cells’
competence for insulin synthesis and secretion [8]. We examined
whether it influenced their typical mRNA expression. After 24 h
of fasting, a 1.5 fold change was detected in 1.5% of all assayed
transcripts (p,0.05), with 95% of altered genes (430 of 452) being
down-regulated (Fig. 6A). Suppression was more marked for the
beta cell marker genes of which 12% were 1.5-fold suppressed (42
transcripts, Fig. 6B). Of these 42 transcripts, 21 expressed genes of
endoplasmic reticulum (ER), ER to Golgi transport, protein folding and
secretory vesicle-mediated transport, i.e. the pathways of protein synthesis
and transport. These genes mostly belonged to cluster C which
shared genes with immune and gut mucosa cells (Fig. 2). In
contrast few changes occurred in the two other clusters: 4 genes
down-regulated in the beta cell selective cluster, and only 1 in the
cluster sharing selectivity with neural cells.
Confirmation of conserved beta cell marker genes at the
protein level
We previously reported a quantitative LC-MS proteome
analysis of FACS-purified rat beta and alpha cells, in comparison
to liver and brain tissues [9]. Analysis of unfractionated cell
proteomes is biased towards the proteins with higher molar
abundance: only 38 proteins coded by the set of 332 beta cell
marker genes (11%) were detected (Table 2). Of these, 12 proteins
(32%) were uniquely detected in the beta cells, at relatively high
molar levels (13 to 105 times above the MS quantification limit).
An additional 9 markers (24%) appeared islet-restricted. 17 (45%)
proteins were also detected in liver and/or brain tissues but
typically at lower abundances than in beta cells. Overall 74% of
detected proteins indeed showed highest abundance in beta cells.
Those that did not were typically shared by alpha and beta cells
with a molar predilection for the alpha cell (e.g. the secretogranins
2, 3 and 5).
Protein phosphatase 1, regulatory (inhibitor) subunit 1A
(PPP1RIA) came out as a novel marker with high molar protein
abundance specifically in beta cells. Molar Ppp1r1a abundance
was similar to that of the established beta cell marker proprotein
convertase subtilisin/kexin type 1 (PCSK1) and 30% of islet
amyloid polypeptide (IAPP) abundance (Table 2). In situ analysis
in rat pancreas confirmed a restricted expression in insulin+ cells
with no protein detected in glucagon+ cells or surrounding
exocrine tissue (Fig. 7 A–B). In situ analysis in human pancreas
also confirmed beta cell-selective expression of protein tyrosine
phosphatase, receptor type, N (PTPRN) alias IA2 (Fig. 7C). Both
markers display an equal beta cell-selectivity as the beta-oxidation
enzyme L-3-hydroxyacyl-CoA dehydrogenase (HADH), shown in
human pancreatic sections in Fig. 7D.
Discussion
Novelty of our beta cell biomarker selection approach
Previous studies have generated gene lists characteristic for
mouse [10], rat [11–13] or human [5,12–16] pancreatic islets,
which represent a resource for novel beta cell biomarkers. Our
study advances these efforts for three reasons.
First, rather than using a rigid score of mRNA expression as
absent/present, a more permissive algorithm was used that
highlights mRNAs with a higher averaged abundance in beta
cells as compared to other tissues and cell types. It zooms in on
genes that are apparently actively transcribed in beta cells without
excluding genes that also have a high expression in other
specialized cells. Indeed, virtually all beta cell markers showed a
varying degree of cell type ‘tropism’ or ‘selectivity’ and can rarely
be considered absolutely beta cell-specific.
Second, our combined data sets made it possible to control for
‘contaminating’ gene markers of other cell types present in
pancreas. Though it is theoretically not excluded that the gene
clusters shared with neuronal or immune/gut tissues arise partly
from contamination with exocrine cells, neurons, endothelial or
blood cells that are co-isolated along with the beta cells, this is
unlikely for several reasons: (i) beta cell marker genes were selected
for their higher expression in purified beta cell preparations –
particularly in the rat with FACS-purifications .90% insulin-
positivity – to whole, freshly frozen tissues. The latter are more
likely to contain blood vessels and blood cells, and also nerve fibers
and ganglia dispersed in the tissue parenchyma, since beta cell
Figure 6. Transcription factor binding sites overrepresented in
the conserved beta cell marker gene set. Using two complemen-
tary search algorithms (Matrix Scan and DiRE), upstream promoter
regions were scanned for statistical enrichment of TRANSFAC-annotat-
ed transcription factor binding consensus sites. Venn diagrams indicate
number of identified matrices by each program, and with 30 commonly
identified matrices indicated in gray field. See Tables S3 and S4.
doi:10.1371/journal.pone.0024134.g006
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content not only discriminates islet beta cells from islet endocrine
non-beta-cells but also from other cell types such as fibroblasts,
leukocytes, and exocrine cells [17]. (ii) The human beta cells were
FACS-isolated from endocrine aggregates after sustained (2–3
weeks) culture, a condition that does not well support survival of
differentiated endothelial, blood and neuronal cells unless specific
growth factors are supplemented. (iii) the gene clusters shared with
neuroendocrine and immune/gut tissues essentially reflect the
secretory and protein biosynthetic specializations, respectively, and
these make sense in the context of the beta cell. (iv) The pancreatic
acinar cell is considered as the cell type with the most specialized
gene expression in the human body [18], so even moderate
contaminations can have strong impact. Indeed, in one reported
list of human islet-specific genes [12] more than half of the top-10
genes belonged to exocrine cells. The FACS-enrichment of human
beta cells to 655% insulin positivity needs improvement but is
currently state-of-the-art. But even with ,1% exocrine contam-
ination as in the rat model, some impact by exocrine contami-
nation on resulting beta cell marker gene list cannot be fully
excluded. Therefore we used the comparison of whole pancreatic
tissue to isolated beta cells in the human data to eliminate
pancreatic exocrine marker genes, mainly of the acinar cell.
Moreover, cultured human beta cells contained much less
exocrine contamination than freshly isolated islets, but also clearly
less than laser microdissected human beta cells.
Third, our focus only on genes that are beta cell abundant in rat,
mouse and human filters out experimental noise due to variability
coming from differences in beta cell isolation techniques and age
differences (standardized adolescent 10-week old rodents versus
47610 adult human beta cells). An added advantage is that the
evolutionary conservation from rodents to man can be seen as an
indirect index for biological significance.
Our approach also has downsides. Not all relevant regulators in
beta cell physiology are conserved: examples are NADP-
dependent malic enzyme (ME1) that is important for glucose-
stimulated insulin secretion in rat and human but not mouse [19],
or cyclin D2, beta cell-abundant in rodents but not humans [20].
Also, expected conserved markers were not identified because of
technical limitations of the array platforms: e.g. SLC30A8 [16] or
FXYD2 [13] were not retrieved since probes for these genes were
not present on the oligonucleotide arrays.
Limits to the concept of beta cell specificity: many shared
traits with other cell types
As first validation, beta cell marker genes were examined for
their natural tissue tropism, by visualization in the independent
Human Gene Atlas data set [3]; this confirmed the power of our
combined marker gene list to discriminate the beta cell from any
other assayed tissue type. Yet at the level of individual marker genes,
both microarray and qPCR findings underline the notion that few
if any genes can be confidently called absolutely beta cell-specific.
Hydrolysis probes-based qPCR detects insulin 2 mRNA also in
brain and intestine albeit at respectively 3 and 5 orders of
magnitude lower than in pancreas. This is not novel since insulin
expression was previously observed in brain, thymus, liver and
bone marrow [21]. ST18 mRNA proved one of the most beta cell-
selective transcripts but was also qPCR-detected in brain, and was
previously observed in the human breast ductal cells [22]. These
low expression-signals could reflect illegitimate (ectopic) expression of
cell type-selective genes [23]. It could alternatively indicate
abundant expression only in one specific cell type within a tissue,
e.g. in small populations of glucose-sensing neurons or endocrine
cells in central nervous system [24,25] and gut [26–28]. Latter
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+
ATP-dependent
membrane channels; gut K-cells can even be engineered to
achieve regulated insulin secretion [29]. Direct comparison of such
cell populations after their purification could disclose even higher
similarity to beta cells, and further limit the notion of beta cell-
specificity. We therefore prefer to use the term of cell type selectivity
rather than specificity, and degree of selectivity likely varies
depending of the number of corresponding mRNA or protein
copies/cell.
Among the conserved beta cell marker genes only 15% show
a near absolute beta cell-selectivity. This gene cluster contains
known beta cell markers (e.g. IAPP, INS1/2, PCSK1, INSM1,
HADH), as well as novel ones, such as (i) ST18,an u c l e a r
protein with tumor suppressor activity [22]; (ii)P r o t e i n
phosphatase 1, regulatory (inhibitor) subunit 1A (PPP1R1A),
known as regulator of muscle activity [30] found to be more
strongly expressed in beta cells where its target protein, protein
phosphatase 1, regulates insulin synthesis. PPP1R1A was shown
here to associate a very high molar abundance in beta cells – as
judged by quantitative LC-MS proteome analysis - to a clear
beta cell-selectivity in rat pancreas which calls for further
exploration of its functional role in beta cells; (iii) FOSB gene
products regulate neuronal plasticity [31] but are 20-times more
abundant in beta cells than in brain and (iv) WNT4, which was
recently linked to the repressed state of canonical Wnt signaling
in beta cells [32].
At least another 15% of the conserved beta cell markers are
clearly shared with neurons. Beta cells are known to express
neuronal traits. They make synaptic-like vesicles containing
glutamate decarboxylase and produce GABA [27,33–36]. Beta cell
development is guided by transcription factors that also control
formation of dopaminergic neurons [35,37–39] e.g. NeuroD1,
Nkx6-1, Foxa2, neurogenins [40]. Also, beta cell progenitors can be
epigeneticallyreprogrammedtoaneuronalphenotypebypolycomb
target derepression via loss of trimethylated histone H3K27 [41],
possibly by shutting down activity of neuron-restrictive silencer
REST [33].The presently reported beta-neuron cluster represents,
to our knowledge, the most comprehensive list of neuronal genes in
beta cells. A third cluster of beta cell marker genes was functionally
enriched in activities of protein folding and processing in the
endoplasmic reticulum. These genes werealso abundant in immune
and gut mucosalcells.The similarity ingene expression between gut
and immune cells may be related to the presence of gastrointestinal-
associated lymphoid cells, which account for 10% of all gut cells
[42]. This cluster does not contain white blood cell-selective clusters
of differentiation nor other immune-selective transcripts, arguing
against contamination as obvious cause for expression similarity.
The conserved beta cell biomarker panel also marks beta
cells obtained in situ by laser capture microdissection
Our conserved beta cell marker genes were selected on beta cell
preparations that underwent isolation and in the human beta cells
Figure 7. In situ analysis of beta cell-selective expression of PPP1R1A, PTPRN and HADH proteins. Panels A and B respectively show
abundant expression of PPP1R1A protein in insulin+ cells and absence in glucagon+ cells in islets from 10 w old rats. Beta cell-selective expression of
PTPRN and HADH proteins in human beta cells is illustrated in panels C and D respectively. All images are representative of at least 3 different organs
with at least 3 sections analyzed per pancreas.
doi:10.1371/journal.pone.0024134.g007
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Since cell isolation can entail a combined mechanical and hypoxic
cell stress, we verified expression level of conserved beta cell
marker genes in human beta cells obtained by laser capture
microdissection, which presumably closely approximates in vivo
expression. We cannot rule out some bias of cell isolation since we
found higher mRNA levels of stress response transcription factor
ATF3 [43] in isolated as compared to laser capture-beta cells; this
likely reflects active ATF3 since we also found statistical
enrichment of its binding sites in the conserved beta cell marker
genes. Yet, overall we found that the conserved beta cell marker
gene panel equally discerns laser capture and isolated beta cells
from all other tissues (Fig. S2) and that the expression levels of
established beta cell marker genes were equal or higher in the
isolated, cultured human beta cells. While cultured beta cells
indeed show statistical enrichment of genes involved in heat shock
and protein folding, they also showed concerted activation of gene
clusters with role in mRNA processing, translation factor activity
and protein processing for secretion, reflecting their higher activity
of regulated protein synthesis, which represents the beta cell’s core
function.
The beta cell biomarker panel is a practical tool to
monitor phenotypic adaptations of the beta cell
The beta cell acutely and chronically adapt to nutrient
stimulations [8,44]. We used the conserved beta cell marker
gene panel as practical tool to see how 24 h fasting impacts on
beta cell differentiated state. While genome-wide comparison
showed that fasting suppresses ,2% of coding genes, it affected
more than 10% of the beta cell marker genes. Interestingly, no
changes occurred in the cluster of beta cell selective genes nor in
that of beta-neuron genes indicating that short-term fasting
preserved the neuroendocrine differentiation. On the other hand,
suppression was clear in the cluster of genes with a role in protein
processing and synthesis, and which thus appear induced by
feeding.
From conserved mRNA expression to conserved
transcriptional regulators
Finally we applied the conserved beta cell marker genes to
partly map the transcriptional network that maintains the
specialized state of nutrient-sensing beta cells. Two entirely
different but complementary searches for conserved transcription
factor consensus motifs showed a substantial overlap, and clearly
highlighted members of the activating transcription factor Atf/
Creb family. Atf2, Atf3 and Atf4 are known regulators of beta cell
function [43,45] and their mRNA appears also abundantly
expressed in these cells. Overrepresentation of binding sites for
several other nutrient-regulated transcription factors (Arnt/Hif,
upstream factors, Oct1, Nfat and Stra13) also fit with their
previously described roles in beta cellular glucose sensing. The
enrichment of Tal1 and Meis1 binding sites fits with the reported
similarities between beta and immune cells since these transcrip-
tion factors were mainly studied as regulator of white blood cell
function. Equally surprising is the enrichment of binding sites for
factors involved in muscle/heart formation (Myogenin, Myod1,
Rfx1, Mrf2). Perhaps the latter is explained by the abundance of
contractile intermediary filaments in beta cells as part of their
secretory vesicle trafficking machinery.
In conclusion, the proposed set of conserved beta cell marker
genes is a practical tool to interpret holistic changes in gene
expression of rodent and human beta cells. It reveals novel beta
cell selective transcripts with potential as physiological regulator.
The gene set also underlines the notion that few if any genes are
absolutely beta cells specific, and highlights functional similarities
of the beta cells with neuronal and immune/gut cells.
Materials and Methods
Cell and tissue preparations
Human pancreas donor organs were procured by European
hospitals affiliated with the Eurotransplant Foundation (Leiden,
the Netherlands) and processed by the Beta-Cell Bank of the
Center for Beta-Cell Therapy in Diabetes. Use of human cells
derived from donor organs was approved by the Medical ethical
committee of the Universitair Ziekenhuis Brussel (UZB), according
to Belgian laws.
Rodents were housed according to the Belgian animal welfare
regulations. Animal killing was kept to the strict minimum, after
proper CO2-anesthesia. Use of animal cells and tissues was
approved by the Commissie Proefdiergebruik (CPG) of the Vrije
Universiteit Brussel (VUB), for a project entitled ‘‘in vitro and in
vivo markers for beta cell death and function’’ (CPG approval ID
07-274-3).
Rat beta (9263% insulin+) and alpha (6869% glucagon+ with
,10% insulin+) cells were FACS-purified from 10-weeks old
Wistar rats as described [46]. Other rat tissues (total brain,
pituitary, M. Soleus skeletal muscle, white adipose tissue and liver
for microarray; for qPCR extended panel as shown in Table 1)
were snap frozen and stored in liquid nitrogen. Mouse islets were
in house isolated from C57/BL6 mice (CERJ, France); mouse
tissue CEL files were obtained from Gene Expression Omnibus
GSE1986. Human beta cells (55613% insulin+ with 1368%
glucagon+ cells and 2167% non-granulated cells) and pancreatic
duct cells (8567% CK+ with 461% insulin+ and 664%
glucagon+) were FACS-sorted from 2–3 w cultured fractions
[47]. We hybridized 3 different pools of 6 mg RNA obtained from
10 human organs in total: pool 1 (45% insulin+, from n=3 donor
organs), pool 2 (65% ins+, from n=3 donor organs) and pool 3
(55% insulin+, from n=4 donor organs). Average donor age and
BMI were 47610 yrs and 2664, respectively. RNA pools from 13
other human tissues were provided by Finn C. Nielsen
(Rigshospitalet, Copenhagen, Denmark).
Gene chip hybridization
Total RNA was isolated using TRIzol Reagent (Invitrogen,
Carlsbad, CA, USA.) and quality-controlled by 2100 Bioanalyzer
(Agilent, Santa Clara, CA, USA), taking RIN.8. One mg RNA
was used to synthesize double-stranded cDNA with the Super-
script Choice system (Invitrogen Corporation, Carlsbad, CA,
USA) using an oligo(dT) primer containing a T7 RNA polymerase
promoter (GenSet, Paris, France) and cDNA was in vitro
transcribed to synthesize biotin-labeled antisense cRNA (BioArray
high yield RNA transcript labelling kit; Enzo Diagnostics,
Farmingdale, NY, USA). After fragmentation at 94uC for
35 min in 40 mM Tris, 30 mM magnesium acetate, 10 mM
potassium acetate, labeled cRNA was hybridized for 16 h on
Affymetrix (Santa Clara, CA, USA) expression arrays. Arrays were
washed and stained with phycoerythrin-streptavidin (SAPE) in
Affymetrix Fluidics Station 400 and scanned in the Affymetrix
GeneArray 2500 scanner. For human beta and duct cells, 3
respectively 2 independent isolates, each obtained from 3–4 non-
selected donor pancreases, were hybridized on Affymetrix
HG133A. Three independent isolates of rat tissues or cells were
hybridized on Affymetrix RG230A. Three independent isolates of
mouse islets were compared to samples from Gene Expression
Omnibus GSE1986 series. CEL files of freshly isolated human
Beta Cell Genes Conserved from Rodents to Humans
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reference [5], and normalized in one group with our human beta
cell CEL files to array with median intensity. Raw data are
publicly available through Gene Expression Omnibus (human
data GSE30803).
Gene chip data analysis Scanned arrays were analyzed with
dChip model-based expression analysis [48] after normalization
to array with median intensity (default) and using background
correction for mismatch hybridization. Excel software was used
to calculate the relative transcript expression in beta cell
preparations versus the other tissues, a ratio further referred to
as ‘fold change’. Within each species, the average of all these
ratios calculated for all assayed tissues is called ‘average fold change’
(avFC). We also calculated a ‘beta cell rank’ to reflect beta cell
selectivity: rank 1, 2, 3,…denotes respectively that the transcript
showed the highest, 2
nd highest, 3
rd highest expression in beta
cells as compared to all other tissues. Selection of conserved beta
cell marker genes is described in Results section. The final set of
beta cell marker genes was independently validated in the
Human Gene Atlas [3], a freely available data set (Gene
Expression Omnibus series GSE1133) comparing duplicate
hybridizations of RNA pools from 79 human primary tissues
and cell types, and further supplemented by our beta and duct
cell samples and previously reported CEL files of human islets
[49]. dChip was also used for hierarchical clustering (correla-
tion/centroid mode by cluster tightness) and gene ontology
enrichment. Gene markers are referred to by their official gene
symbol, in capitalized italic font.
Bioinformatics enrichment analysis of cis-regulatory
motifs in the promoters of beta cell marker genes
We used the whole collection of TRANSFAC matrices (442
matrices for human, 392 for mouse and 243 for rat). Using
retrieve-ensembl-seq [50], promoter sequences were retrieved
over 2,000 bp upstream the transcription start site, masking the
coding sequences of upstream genes; in a separate file the first
intron of each gene (median length=3,845 bp) was collected.
Repeats were masked in both promoter and intron sequences.
Site enrichment analysis. Enrichment analysis was led with the
program matrix-scan [7], which automatically estimates the
enrichment of sites for a given motif in a given input sequence
for all possible matrix weight score thresholds. The weight score
indicates the similarity between a sequence and the motif, as
defined as by Hertz and Stormo [51]. For each motif, matrix-
scan computes the number of hits in the input sequences above
each possible weight score threshold, and compares it with the
number of hits expected by chance, according to the background
model. The level of the over-representation is estimated with the
binomial P-value [52,53], which is converted to a significance
score defined as sig=2log10 (P val). The program returns the
optimal matrix score, i.e. the weight score associated to the
minimal P-value. The background model was estimated from the
input sequences, as a Markov model of order 1. The first-order
model enables to account for dependencies between adjacent
residues, which is especially important to model the general
rarity of the CpG dinucleotide in vertebrate promoters. Negative
control As negative control, we permuted randomly the columns
of the TRANSFAC matrices, and applied the same procedure as
with the original matrices. The main interest of that type of
control is that it preserves the residue composition and the
information content while removing the actual motif. As
complementary approach, DiRE (http://dire.dcode.org/) was
used using default settings [6].
Validation of relative beta cell abundant mRNAs by
quantitative real-time PCR using hydrolysis probes
Hydrolysis probes were obtained from Applied Biosystemes
(TaqMan MGB, assays’ IDs available on request) using 4 reference
genes (beta-actin, BACT; cyclophilin A/peptidyl prolyl isomerase
A, PPIA, ubiquitin C, UBC and proteasome 26S subunit, ATPase
5, PSMC5) for normalization along the GEOnorm principle [4].
Validation of beta cell-selective protein expression by
quantitative label-free LC-MS and immunohistochemistry
The proteomes of unfractionated rat liver, brain and FACS-
purified islet alpha and beta cells were previously quantified using
label-free alternate-scanning LC-MS [9]. Selected markers were in
situ confirmed 10w-old male Wistar rat and/or human pancreas.
Primary antibodies were rabbit anti-human PPP1R1A (1:1000),
chicken anti-human PTPRN (1:500) and chicken anti-human
HADH (1:1000) all from Genway (San Diego, CA, USA.
PPP1R1A staining worked best on paraffin sections, IA2 and
HADH staining best on tissue fragments fixed for 30 min in 4%
formaldehyde followed by overnight incubation in 30% sucrose
prior to snap freezing in liquid nitrogen and cryosectioning. Non-
specific staining was blocked with 10% donkey serum in PBS,
followed by overnight incubation at 4uC with primary antibodies,
60 min with secondary antibodies and addition of bisbenzimide
(Hoechst 33342, Sigma). Secondary antibodies (dylight 488 for
markers, dylight 649 for insulin and glucagon) were from Jackson
Immunoresearch Laboratories (West Grove, PA, USA).
Statistical analysis
Data are presented as arithmetic or geometric means 6 SD or
SE of n independent experiments; statistics used by dChip, DiRE)
and Matrix Scan outlined above or in original publications.
Supporting Information
Figure S1 View on exocrine contamination and its
removal from our beta cell marker gene list. Fig. S1A
shows a hierarchical clustering of 526 probe sets corresponding to
human genes with species-conserved relative beta cell abundant
expression, including 17 exocrine contaminants (cluster marked in
blue) that uniquely expressed in pancreatic samples with strongest
expression in total pancreas.islets.FACS-sorted beta cells. Bar
graphs in Fig. S1B highlight the individual genes in this cluster;
most correspond to digestive enzymes, and are markers for
exocrine acinar cells. Note that cultured, FACS-purified human
beta cell preparations used in our study show minimal contam-
ination with exocrine markers as compared to freshly isolated
whole human islets. Expression signal in total pancreas and whole
islets are comparable; note that this probably represents an artifact
of the oligonucleotide array technique: due to probe saturation by
highly abundant mRNAs, expression signal is no longer linearly
related to actual mRNA concentration.
(TIF)
Figure S2 Beta cell marker genes discriminate beta
cells from any other cell type in the body. Fig. S2 shows a
2-dimensional principle component analysis (PCA) of the 332
species-conserved mRNAs (n=503 probe sets) with relative beta
cell abundant expression in the tissue mRNA profiles of the
human GSE1133 data set, containing duplicate hybridizations of
RNA pools obtained from human tissues or cells [3]. This data set
was supplemented by Affymetrix hybridizations of FACS-enriched
cultured human beta cells (obtained from Beta Cell Bank, Brussels,
Belgium, data point 1, n=3 hybridizations on cells from 10
Beta Cell Genes Conserved from Rodents to Humans
PLoS ONE | www.plosone.org 13 September 2011 | Volume 6 | Issue 9 | e24134donors) and freshly isolated human islets (data point 2) and laser
capture microdissected human beta cells (data point 3) – the latter
two preps representing n=3 hybridizations each from one donor,
and previously published by Marselli L. et al. [5] from Joslin
Diabetes Center, Harvard, USA. The PCA illustrates that the
conserved beta marker genes can discriminate beta cell from all
other tissues in a data set independent from the one used to
compile it; it also shows that the biomarkers can equally
discriminate isolated and laser capture beta cells. X- and Y-axes
of the PCA represent respectively the major and minor
components of variation.
(TIF)
Figure S3 View on brain region-tropism of shared
neuron-beta cell marker genes. Bar graphs show relative
mRNA expressionsignal (human HG133Aarray),inthe human beta
cells as compared to the indicated brain region, of 15 beta cell marker
genesthatarealsoabundantlyexpressedinthehumanbrain(meanof
2–3 hybridizations). Left panel shows these data for 15 shared beta
cell-neuron marker genes, while right panel shows the median ratio
for a given brain region. Selected beta cell marker genes reach highest
levels in globus pallidus and nucleus subthalamicus.
(TIF)
Figure S4 Focus on gene cluster with shared relative
abundant expression in gut, hematological and beta
cells as evidenced by hierarchical cluster graph from
Figure 1. Associated table shows gene symbols and names,
accession number and for each species the associated avFC and
rank scores. Table on left panel shows functional pathways that are
statistically overrepresented in this cluster, using dChip gene
ontology enrichment (p,0.05).
(TIF)
Table S1 332 genes with species-conserved relative
abundant expression in beta cells. Table S1 shows 419,
499 and 503 probe sets on respectively rat (RG230A, blue), mouse
(MG430.20, green) and human (HG133A, red) Affymetrix
microarrays. These correspond to 332 genes, since Affymetrix
chips associate multiple probe sets to the same genes. In 2
nd
column the genes belonging to cluster A (neuroendocrine), B (beta
cell-selective) or C (gut/immune) of Fig. 2 are indicated. Table also
shows for each species probe set IDs, Accession/Locuslink ID,
average fold change and beta score ranging from minus to plus 6
in rat, 14 in human and 17 in mouse. Note: for user-friendly
display and to allow direct comparison of between homologous
probe sets of different species, some probe sets are shown more
than once when number of probe sets per gene differs between
species, so that all rows contain values and can easily be sorted.
(PDF)
Table S2 Statistically overrepresented functional gene
ontologies in cultured versus laser capture microdis-
sected human beta cells. 2736 probe sets were $1.5 fold
(LCB) up-regulated (p,0.05, n=3) in cultured FACS-enriched
versus laser capture microdissected (LCM) human beta cells.
Table S2 shows the functional gene ontologies that are statistically
(p,0.001) overrepresented in the cultured (blue) versus LCM
(green) beta cells. For comparison corresponding mRNA expres-
sion signals in freshly isolated islets (red) and statistics versus LCM
beta cells are also shown. Cultured FACS-enriched beta cells show
a concerted up-regulation of the transcriptional-protein synthetic
pathway, starting from mRNA splicing and processing, transla-
tional initiation and ribosomal RNA to protein folding in
endoplasmic reticulum and subsequent processing through Golgi
apparatus to the secretory vesicle.
(PDF)
Table S3 DiRE analysis of transcriptional regulators of
the beta cell phenotype. DiRE was used to retrieve
transcription factor binding sites (TFBs) that are statistically
overrepresented in beta cell marker genes versus random reference
gene sets (65000 genes) of the human (hg18), mouse (mm9) and
rat (rn4) genomes. Score indicate statistical importance (ranging
from 0 to 1). For each species, the analysis was run on the whole
set of beta cell markers (all), and also separately on the 3
outstanding clusters of neuro-endocrine genes (cluster A, see Fig. 3),
beta cell-selective genes (cluster B, see Fig. 2) and markers shared
with immune and gut cells (cluster C, see suppl. Fig. 3) genes. Data
(human analysis) are graphically presented in Fig. 6.
(PDF)
Table S4 Transcription factor consensus sites identi-
fied by 2 independent algorithms. DNA consensus sites
(TRANSFAC) with potential for transcription factor binding were
identified by DiRE and Matrix Scan; 27 consensus sites were
identified by both algorithms (ochre), 27 only by the more
stringent Matrix Scan (blue), and 77 only by DiRE (yellow).
Marked in bold are transcription factors with established role in
beta cell development and physiology Data are graphically
presented in Fig. 6.
(PDF)
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